Джиджи Ворган – В здравом уме и твердой памяти. Программа профилактики болезни Альцгеймера (страница 47)
Sorrells, S. F., et al. “The stressed CNS: when glucocorticoids aggravate inflammation.”
Shackman, A. J., et al. “Stress potentiates early and attenuates late stages of visual processing.”
Newcomer, J. W., et al. “Decreased memory performance in healthy humans induced by stress-level cortisol treatment.”
Buchanan, T. W., and W. R. Lovallo. “Enhanced memory for emotional material following stress-level cortisol treatment in humans.”
Simpson, N., and D. F. Dinges. “Sleep and inflammation.”
Troxel, W. M., et al. “Sleep symptoms predict the development of the metabolic syndrome.”
Stickgold, R. “Sleep-dependent memory consolidation.”
Morin, C. M., et al. “Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of helpseeking behaviors.”
Rubinstein, J. S., et al. “Executive control of cognitive processes in task switching.”
Hölzel, B. K., et al. “Mindfulness practice leads to increases in regional brain gray matter density.”
Davanger, S., et al. “Meditation-specific prefrontal cortical activation during acem meditation: an fMRI study.”
Newberg, A. B., et al. “Meditation effects on cognitive function and cerebral blood flow in subjects with memory loss: A preliminary study.”
Slagter, H. A., et al. “Mental training affects distribution of limited brain resources.”
Slavich, G. M., et al. “Neural sensitivity to social rejection is associated with inflammatory responses to social stress.”
Wang, C., et al. “A randomized trial of tai chi for fibromyalgia.”
Lam, L. C., et al. “Interim follow-up of a randomized controlled trial comparing Chinese style mind body (Tai Chi) and stretching exercises on cognitive function in subjects at risk of progressive cognitive decline.”
Irwin, M. R., et al. “Major depressive disorder and immunity to Varicella-Zoster virus in the elderly.”
Stein, M. B., et al. “A prospective community study of adolescents and young adults.”
Bryant, C., et al. “The prevalence of anxiety in older adults: Methodological issues and a review of the literature.”
Goldin, P. R., et al. “The neural bases of amusement and sadness: a comparison of block contrast and subject-specific emotion intensity regression approaches.”
Leichsenring, F., and S. Rabung. “Effectiveness of long-term psychodynamic psychotherapy: a metaanalysis.”
Alzheimer’s Foundation of America Survey. “Americans with Memory Concerns Fall Short of Talking to Doctors.” http://www.alzfdn.org/MediaCenter/073008.html.
Fox, S. “Online health search 2006.” Pew Internet & American Life Project. October 29, 2006. www.pewinternet.org/Reports/ 2006/Online-Health-Search-2006.aspx.
Kasper, J., et al. “Turning signals into meaning: ‘Shared decision making’ meets communication theory.”
Elwyn, G., et al. “Achieving involvement: process outcomes from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice.”
Schwartz, E., et al. “Cardiovascular risk factors affect hippocampal microvasculature in early AD.”
Braskie, M. N., et al. “Vascular health risks and fMRI activation during a memory task in older adults.”
Godin, O., et al. “Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study.”
Li, J., et al. “Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease.”
Lin, F. R., et al. “Hearing loss and incident dementia.”
Reitz, C., et al. “Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of lateonset Alzheimer disease.”
Bettermann, K., et al. “Statins, risk of dementia, and cognitive function: Secondary analysis of the Ginkgo Evaluation of Memory Study.”
De Felice, F. G., et al. “Protection of synapses against Alzheimer’s-linked toxins: Insulin signaling prevents the pathogenic binding of A_ oligomers.”
Szekely, C. A., et al. “No Advantage of A_42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies.”
Small, G. W., and L. F. Jarvik. “The dementia syndrome.”
Radimer, K., et al. “Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999–2000.”
Small, G. W. “Beyond standard anti-dementia therapies: Diet, exercise, socialization, and supplements:
Usharani, P., et al. “Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study.”
Hubbard, W. K. “Letter updating the phosphatidylserine and cognitive function and dementia qualified health claim.” FDA U.S. Department of Health and Human Services. November 24, 2004. http://www.fda.gov/Food/LabelingNutrition/LabelClaims/QualifiedHealth- Claims/ucm072993.htm.
Vakhapova, V., et al. “Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in nondemented elderly with memory complaints: a double-blind placebo-controlled trial.”
Kato-Kataoka, A., et al. “Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints.”
Honein, M. A., et al. “Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects.”
Hooshmand. B., et al. “Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study.”
Riggs, K. M., et al. “Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study.”
Smith, A. D., et al. “Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.”
Politis, A., et al. “Vitamin B12 levels in Alzheimer’s disease: association with clinical features and cytokine production.”
Iwamoto, J., et al. “Prevention of hip fractures by exposure to sunlight and pharmacotherapy in patients with Alzheimer’s disease.”
Annweiler, C., et al. “Vitamin D and ageing: neurological issues.”
Llewellyn, D. J., et al. “Vitamin D and risk of cognitive decline in elderly persons.”
Annweiler, C., et al. “Dietary intake of vitamin D and cognition in older women: a large population-based study.”
Sano, M., et al. “A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease.”
Miller, E. R., et al. “Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality.”
Devore, E. E., et al. “Dietary antioxidants and long-term risk of dementia.”
Gray, S. L., et al. “Antioxidant vitamin supplement use and risk of dementia or Alzheimer’s disease in older adults.”
DeKosky, S. T., et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial.”
Lopez, L. B., et al. “High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo study.”
Quinn, J. F., et al. “Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.”
Scholey, A., et al. “Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo- controlled, crossover study.”